Upgrade to SI Premium - Free Trial

Cerenome (CNSY)

2.14 -0.03 (1.38%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Form 8-K CERENOME, INC. For: Sep 04 September 10, 2026 8:01 AM - SEC Filing Cerenome secures $20M financing deal with royalty-based repayments September 10, 2026 7:15 AM - StreetInsider Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment September 10, 2026 7:15 AM - Globe NewsWire Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines August 20, 2026 7:30 AM - Globe NewsWire Form 10-Q CERENOME, INC. For: Jun 30 August 14, 2026 4:40 PM - SEC Filing Form 8-K CERENOME, INC. For: Aug 14 August 14, 2026 4:28 PM - SEC Filing Cerenome Reports Second Quarter 2026 Financial Results and Business Update August 14, 2026 4:15 PM - Globe NewsWire Cerenome signs HCSC coverage deal, topping 150M covered lives August 13, 2026 7:31 AM - StreetInsider Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding CNSide® Contracted Coverage to Over 150 Million Covered Lives August 13, 2026 7:30 AM - Globe NewsWire Cerenome picks XiFin for billing services on CNSide platform August 6, 2026 7:31 AM - StreetInsider Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform August 6, 2026 7:30 AM - Globe NewsWire Plus Therapeutics rebrands to Cerenome, changes ticker to CNSY July 31, 2026 8:31 AM - StreetInsider Cerenome Launches as an Integrated CNS Oncology Company July 31, 2026 8:30 AM - Globe NewsWire Plus Therapeutics to rebrand as Cerenome, trade as CNSY on Aug. 3 June 30, 2026 7:31 AM - StreetInsider Full Article List